معرفی
Kaicheng Wang is a Biostatistician in the Department of Biostatistics at the Yale School of Public Health. He holds a MD from West China Medical School of Sichuan University (2016) and an MPH from the University of Miami, Miller School of Medicine (2019). His research focuses on epidemiological analyses of migraine, cardiovascular health, infectious diseases (e.g., malaria), and healthcare policy, with a particular emphasis on veterans' health and telehealth utilization. He collaborates with institutions like the Veterans Health Administration and contributes to studies addressing opioid prescribing trends, antimalarial drug efficacy, and pandemic-related healthcare shifts. His work often integrates biostatistical methods to evaluate clinical outcomes and public health interventions.
Notable research interests include the intersection of neurology and public health, particularly migraine management and cardiovascular risk assessment. He also explores global health challenges, such as malaria treatment in HIV-positive children in Uganda, and the impact of electronic consultations on healthcare systems. Dr. Wang has published extensively on topics like SARS-CoV-2 infection risks in rheumatic diseases and T-cell dysfunction in HIV-associated cancers.
His articles highlight trends in headache epidemiology, opioid use during the pandemic, and telemedicine's role in healthcare delivery. He has contributed to studies on vaccine efficacy, clinical trial design for antimalarial treatments, and kidney transplant outcomes. Grants and collaborations include work with the NIH and VA systems, focusing on improving healthcare accessibility and evidence-based practices.
Dr. Wang is affiliated with labs and teams at YSPH, particularly those addressing public health data science and equity. His future work aims to advance biostatistical methodologies for analyzing complex health systems and patient outcomes, with a focus on translating research into actionable public health strategies.
